Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Haruo, Horiai"'
Autor:
Yutaka Kohno, Takahiro Kusunoki, Haruo Horiai, Youichi Shiokawa, Yoshio Uehara, Atushi Akahane, Takao Terai, Keizo Yoshida, Yasuhiro Kita
Publikováno v:
Cardiovascular Drug Reviews. 15:44-58
Adenosine is a purine nucleotide that is widely distributed throughout the body; it modulates a wide variety of physiological functions via extracellular receptors. Adenosine receptors, located on the cell membranes, are classified into two major sub
Autor:
Yutaka Kohno, Haruo Horiai, Yasuhiro Kita, Keiko Nakano, Yasuhiro Mine, Noriko Nishina, Takao Terai, Keizo Yoshida, Takahiro Kusunoki
Publikováno v:
Drug Development Research. 39:47-53
The purpose of the present study was to examine the protective effect of FK453, (+)-(R)-1-[(E)-3-(2-phenylpyrazolo [1,5-a] pyridin-3-yl) acryloyl]-2-piperidine ethanol, a potent non-xanthine (adenosine A1 receptor antagonist, on glycerol-induced acut
Autor:
Takeshi Andoh, Takao Terai, Yasuhiro Kita, Haruo Horiai, Atsushi Akahane, Takahiro Kusunoki, Youichi Shiokawa, Keizo Yoshida, Itzuo Nagatomi
Publikováno v:
Drug Development Research. 36:25-34
The renal effects of FK453, a potent and selective non-xanthine adenosine A 1 receptor antagonist, were examined and compared with FR113452 (less active enantiomer of FK453), typical adenosine receptor antagonists, and diuretics. In rats FK453 posses
Autor:
Takaharu Ono, Miho Sato, Yoshihiko Sakata, Haruo Horiai, Jiro Seki, Yasuko Namikawa, Yukio Motoyama
Publikováno v:
Thrombosis Research. 65:55-63
TFC-612 inhibited thrombus formation on wire coils inserted into the lumen of the inferior vena cava of rats after 5 oral doses of 1.0 and 3.2 mg/kg and subcutaneous doses of 1.0 and 3.2 pg/rat/hr. This compound showed slight inhibition of platelet a
Autor:
Jiro Seki, Yukio Motoyama, Takashi Asada, Yoshihiko Sakata, Haruo Horiai, Yasuko Namikawa, Takaharu Ono
Publikováno v:
Thrombosis Research. 63:29-38
The anti-platelet activities of TFC-612, methyl 6-(((1R, 2S, 3R)-3-hydroxy-2-((1E, 3S, 5R)-3-hydroxy-5-methyl-1-nonenyl)-5- oxocyclopentyl) thio)hexanoate, were compared to prostaglandin E1 (PGE1). TFC-612 inhibited human, guinea-pig and rabbit plate
Autor:
Takeshi, Inoue, Haruo, Horiai, Chizuru, Aoki, Ikuo, Kawamura, Mariko, Ota, Hidekazu, Mizuhara, Masaaki, Tomoi, Seitaro, Mutoh
Publikováno v:
In vivo (Athens, Greece). 17(3)
The aim of this study was to evaluate the effect of insulin-like growth factor-I (IGF-I) on lethality and liver function in experimental acute liver failure. Intravenous co-administration of D-galactosamine (GalN) and lipopolysaccharide (LPS) to rats
Autor:
Masako Hayashi, Hitoshi Sasaki, Yoshinori Ishii, Masakazu Kobayashi, Shingo Suzuki, Haruo Horiai, Takashi Asada, Joji Notani, Mineo Niwa, Fumio Shibayama, Yoshimasa Saito, Satoshi Koyama
Publikováno v:
Annals of the New York Academy of Sciences. 613:452-454
Autor:
Masako Hayashi, Mineo Niwa, Takao Fujimura, Yuko Imai, Haruo Horiai, Hitoshi Sasaki, Yoshinori Ishii, Masakazu Kobayashi, Yoshimasa Saito, Takashi Asada, Joji Notani, Sachiko Nakamura, Shingo Suzuki
Publikováno v:
Biotechnology progress. 10(5)
We have created a novel thrombolytic agent by the combination of mutation with partial deletion of tissue-type plasminogen activator (t-PA). We constructed Escherichia coli expression vectors for (i) native t-PA (nt-PA) and its derivatives; (ii) K1K2
Autor:
Kyoichi Shimomura, Fusako Nishigaki, Takahiro Kusunoki, Haruo Horiai, H. Minoura, K. Nakano, Toshitaka Manda, Y. Kotino, Takao Terai, M. Otsuka
Publikováno v:
Japanese Journal of Pharmacology. 67:317
Autor:
Yutaka Kohno, Minoru Ohtsuka, Masahiro Takeda, Kimio Esumi, Haruo Horiai, Kyoichi Shimomura, Masashi Imai
Publikováno v:
Japanese Journal of Pharmacology. 64:176